[1]黄海平 聂开兰 何娜 李正胜.益肾汤经结肠透析对慢性肾脏病3~5期患者肠道菌群、微炎症的影响[J].国际中医中药杂志,2021,43(12):1199-1203.[doi:10.3760/cma.j.cn115398-20210225-00186]
 Huang Haiping,Nie Kailan,He Na,et al.Effect of Yishen Decoction on intestinal microflora and microinflammation for the patients with stage 3-5 chronic kidney disease[J].,2021,43(12):1199-1203.[doi:10.3760/cma.j.cn115398-20210225-00186]
点击复制

益肾汤经结肠透析对慢性肾脏病3~5期患者肠道菌群、微炎症的影响

参考文献/References:

[1].Hoshino J,Muenz D,Zee J,et al. Associations of Hemoglobin Levels With Health-Related Quality of Life,Physical Activity,and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD[J]. J Ren Nutr,2020,30(5):404-414. DOI:10.1053/j.jrn.2019.11.003.
[2].Mitsides N,Alsehli F,Mc Hough D,et al. Salt and Water Retention Is Associated with Microinflammation and Endothelial Injury in Chronic Kidney Disease[J]. Nephron,2019,143(4): 234-242. DOI:10.1159/000502011.
[3].张舒飞,朱琳,周萍. 慢性肾脏病与肠道菌群相关性的研究进展[J]. 实用医学杂志,2020,36(12):1684-1688. DOI:10.3969/ j.issn.1006-5725.2020.12.027.
[4].Wong J,Davis P,Patidar A,et al. The Effect of Intra-Dialytic Exercise on Inflammation and Blood Endotoxin Levels[J]. Blood Purif,2017,44(1):51-59. DOI:10.1159/000455059.
[5].张晓霞,王蕊花,毕红梅,等. 结肠透析配合益肾汤对CKD3~4期颈动脉钙化患者NF-B、TNF-α的影响[J]. 中国中西医结合肾病杂志,2018,19(6):511-513. DOI:10.3969/j.issn. 1009-587X.2018.06.014.
[6].常沁涛,张晓东,王蕊花,等. 益肾汤经结肠透析对慢性肾脏病颈动脉钙化患者血镁及炎症因子的影响[J]. 中国中西医结合肾病杂志,2018,19(4):317-318. DOI:10.3969/j.issn. 1009-587X.2018.04.012.
[7].Vassalotti JA,Stevens LA,Levey AS. Testing for chronic kidney disease:a position statement from the National Kidney Foundation[J]. Am J Kidney Dis,2007,50(2):169-180. DOI:10. 1053/j.ajkd.2007.06.013.
[8].Bauer C,Melamed ML,Hostetter TH.Staging of chronic kidney disease:time for a course correction[J]. J Am Soc Nephrol, 2008,19(5):844-846. DOI:10.1681/ASN.2008010110.
[9].郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002:163-168.
[10].胡振奋,黄蔚霞,吴睿轩,等. 补肾泄浊法对慢性肾脏病3-5期患者中医证候及矿物质骨代谢的影响[J]. 中国中医急症,2017, 26(11):2011-2014. DOI:10.3969/j.issn.1004-745X.2017.11.039.
[11].包能,于翔,陈笑,等. 结肠透析联合中药灌肠治疗慢性肾脏病的Meta分析[J]. 中医药导报,2018,24(14):87-92. DOI:10. 13862/j.cnki.cn43-1446/r.2018.14.030.
[12].张小娟,蒋珍秀,董娜. 基于肠道微生态及“肠-肾轴”理论探讨慢性肾脏病从脾论治机理[J]. 中国中医药信息杂志,2020, 27(6):14-17. DOI:10.3969/j.issn.1005-5304.201903372.
[13].Ma JH,Peng YJ,Sun JH,et al. [Possibility of acupuncture treatment of ischemic stroke via regulating intestinal flora-immune response][J]. Zhen Ci Yan Jiu,2019,44(7): 538-542. DOI:10.13702/j.1000-0607.180786.
[14].Hu J,Zhong X,Yan J,et al. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients[J]. BMC Nephrol,2020,21(1):12. DOI:10.1186/ s12882-019-1668-4.
[15].Olivier V,Dunyach-Remy C,Corbeau P,et al. Factors of microinflammation in non-diabetic chronic kidney disease:a pilot study[J]. BMC Nephrol,2020,21(1):141. DOI:10.1186/ s12882-020-01803-y.
[16].de Sequera P,Corchete E,Bohorquez L,et al. Residual Renal Function in Hemodialysis and Inflammation[J]. Ther Apher Dial,2017,21(6):592-598. DOI:10.1111/1744-9987.12576.
[17].Durlacher-Betzer K,Hassan A,Levi R,et al. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease[J]. Kidney Int,2018,94(2):315-325. DOI:10.1016/j.kint.2018.02.026.
[18].Mavrakanas TA,Khattak A,Singh K,et al. Echocardiographic parameters and renal outcomes in patients with preserved renal function,and mild- moderate CKD[J]. BMC Nephrol,2018, 19(1):176. DOI:10.1186/s12882-018-0975-5.
[19].Hsieh YP,Chang CC,Yang Y,et al. The role of uric acid in chronic kidney disease patients[J]. Nephrology (Carlton), 2017,22(6):441-448. DOI:10.1111/nep.12679.
[20].Ji YQ,Guan LN,Yu SX,et al. Serum sclerostin as a potential novel biomarker for heart valve calcification in patients with chronic kidney disease[J]. Eur Rev Med Pharmacol Sci,2018, 22(24):8822-8829. DOI:10.26355/eurrev_201812_16650.

相似文献/References:

[1]王高强 沈丽萍 张玮 李珺 倪家庆 米秀华.实脾固肾化瘀方对阿霉素肾纤维化大鼠肾组织I型胶原蛋白、转化生长因子b1、层黏连蛋白及a平滑肌肌动蛋白表达的影响[J].国际中医中药杂志,2014,36(11):1009.[doi:10.3760/cma.j.issn.1673-4246.2014.11.015]
 Wang Gaoqiang,Shen Liping,Zhang Wei,et al.Effects of Shipi-Gushen-Huayu Recipe on the expressions of collagen I, laminin, transforming growth factor-β1 and α-smooth muscle actin in adriamycin-induced renal fibrosis in rats[J].,2014,36(12):1009.[doi:10.3760/cma.j.issn.1673-4246.2014.11.015]

备注/Memo

(收稿日期:2021-02-25)

更新日期/Last Update:

2021-12-16